Funds holding VanEck Pharmaceutical ETF
ISIN US92189F6925 · United States · LEI 5493008SDOYUHMC8LF44
- Fund holders
- 1
- Of which ETFs
- 1 0 other funds
- Value held
- 708.6K $
A single tracked fund declares this security: these figures do not say who holds it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Leuthold Core ETF Managed Portfolio Series | 6,821 | 708.6K $ | 1.04 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures how much this security weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Leuthold Core ETF Managed Portfolio Series | 1.04 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 6,821 | -15.9 % |
| 2026Q1 | 1 | -1 | 8,108 | -15.4 % |
| 2025Q2 | 2 | +1 | 9,585 | +63.2 % |
| 2024Q4 | 1 | 0 | 5,873 | +6,891.7 % |
| 2024Q2 | 1 | 0 | 84 | -99.9 % |
| 2023Q4 | 1 | 124,304 |
Institutional managers
147 managers declare this security to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 986,112 | 102.4M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 811,299 | 84.3M $ | as of Mar 31, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 561,000 | 58.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 549,000 | 57M $ | as of Mar 31, 2026 |
| BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp | 545,207 | 56.6M $ | as of Mar 31, 2026 |
| Employees Retirement System of Texas | 531,600 | 55.2K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 361,001 | 37.5M $ | as of Mar 31, 2026 |
| J.Safra Asset Management Corp | 310,801 | 32.3M $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 304,499 | 31.6M $ | as of Mar 31, 2026 |
| Avalon Trust Co | 267,700 | 27.8M $ | as of Mar 31, 2026 |
| CITIGROUP INC | 219,624 | 22.8M $ | as of Mar 31, 2026 |
| GTS SECURITIES LLC | 202,425 | 21M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 177,847 | 18.5M $ | as of Mar 31, 2026 |
| ADAMSBROWN WEALTH CONSULTANTS LLC | 148,811 | 15.5M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 143,609 | 14.9M $ | as of Mar 31, 2026 |
| Miller Investment Management, LP | 133,938 | 13.9M $ | as of Mar 31, 2026 |
| LPL Financial LLC | 112,240 | 11.7M $ | as of Mar 31, 2026 |
| Prime Capital Investment Advisors, LLC | 92,917 | 9.7M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 84,211 | 8.7M $ | as of Mar 31, 2026 |
| FLOW TRADERS U.S. LLC | 82,371 | 8.6K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 67,086 | 7M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 55,225 | 5.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 54,964 | 5.7M $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 51,090 | 5.3M $ | as of Mar 31, 2026 |
| WT Wealth Management | 50,384 | 5.2M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding VanEck Pharmaceutical ETF". https://titelia.com/en/stocks/vaneck-pharmaceutical-etf-US92189F6925